Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):400-405. (PUBMED - Site de la revue)
 
Agnelli Giacchello J, Valeri F, Boccadoro M, Borchiellini A. Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia. Eur J Haematol. 2018 Mar;100(3):304-307. (PUBMED - Site de la revue)
 
Higashide Y, Hori T, Yoto Y, Kabutoya H, Honjo S, Sakai Y et al. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura. Pediatr Int. 2018 Apr;60(4):357-361. (PUBMED - Site de la revue)
 
Ahmed AR, Kaveri S. Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin. Front Immunol. 2018 Jul 18;9:1189 (PUBMED - Site de la revue)
 
Kanhai D, Mulder R, Ploos van Amstel HK, Schutgens R, Lukens M, Tamminga RYJ. Familial macrothrombocytopenia due to a double mutation in cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura. Pediatr Blood Cancer. 2018 Aug 19:e27418. . (PUBMED - Site de la revue)
 
Howie HL, Hudson KE. Murine models of autoimmune hemolytic anemia. Curr Opin Hematol. 2018 Aug 30. (PUBMED - Site de la revue)
 
Araki R, Nishimura R, Kuroda R, Fujiki T, Mase S, Noguchi et al. A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP). Int J Hematol. 2018 Aug;108(2):151-160 . (PUBMED - Site de la revue)